Clinical Trial: A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Study Status: COMPLETED
Recruit Status: COMPLETED
Study Type: OBSERVATIONAL

Official Title: Clinical Characteristics and Mortality in Patients With Fibrodysplasia Ossificans Progressiva (FOP): A Non-Interventional US National Retrospective Cohort

Brief Summary:

Primary Objective(s):

  • To describe the demographic characteristics of people living with FOP
  • To describe the prevalence of clinical characteristics of interest in people living with FOP
  • To describe the use of key medications in people living with FOP
  • To estimate the crude mortality rate among people with FOP

Detailed Summary:
Sponsor: Regeneron Pharmaceuticals

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Regeneron Pharmaceuticals

Dates:
Date Received: September 11, 2023
Date Started: June 29, 2023
Date Completion: June 29, 2023
Last Updated: October 24, 2023
Last Verified: October 01, 2023